Genomic Testing Would Benefit From Traceability, Standardization – Mayo's Klee
This article was originally published in The Pink Sheet Daily
Executive Summary
Manufacturers that participate in developing reference standards will have an advantage, Klee says. An FDA Rx/diagnostic co-development guidance is expected this year.